Shria Kumar

Shria Kumar practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Shria Kumar's NPI, 1912325804, was assigned on March 29, 2014. Shria Kumar graduated from Albert Einstein College of Medicine in 2014. Shria Kumar holds Florida license ME149836.

Shria Kumar's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Shria Kumar's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Shria Kumar is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Shria Kumar to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Shria Kumar practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Shria Kumar's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Shria Kumar is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Shria Kumar's licenses on file in 3 states: Florida, Pennsylvania and New York.

Dmand AI lists acid reflux, colonoscopy, irritable bowel syndrome (IBS), pancreas or bile duct endoscopy (ERCP) and upper GI endoscopy among the conditions Shria Kumar treats.

CMS data shows 137 Medicare services from Shria Kumar across 6 procedure codes in 2024, for 124 Medicare patients. Medicare paid $13,284 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 124 Medicare patients who saw Shria Kumar in 2024. The largest group is 65 to 74, with 55 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Shria Kumar's median patient age at 71, with 57% women.

In 2024, Shria Kumar wrote 113 Medicare Part D claims for 64 patients. 84% of them were for generic drugs. CMS names the drug for 56 of them, across 3 drugs with 11 or more claims each, at $956 in total drug cost. In 2023, CMS named 33 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Shria Kumar for performance year 2024, reported as part of a group. Shria Kumar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Shria Kumar as offering telehealth. CMS counts 131 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Shria Kumar, more than 82% of the clinicians it reports for that procedure.

Dmand AI links 48 papers to Shria Kumar, published from 2016 to 2025. 2022 was the busiest year, with 8. The most frequent topics are Stomach Neoplasms, Helicobacter Infections and Helicobacter pylori. Shria Kumar has published most often in Clin Gastroenterol Hepatol. Shria Kumar's most frequent co-authors are David S. Goldberg, MD, Bryson William Katona, MD, PhD and David C. Metz, MD.

CMS Open Payments shows 16 general payments to Shria Kumar from 5 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $838.

Dmand AI lists 1 award for Shria Kumar.

Shria Kumar graduated from Albert Einstein College of Medicine in 2014. Shria Kumar is a member of ASCO.

Shria Kumar is in network with 11 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.